Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin
Introduction | Browse | Search | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| - | 1,2-DAG(35:1) | cPLA2i | 1.0 | BCD110605C28 | 2.32 | pmol/sample |
| - | 1,2-DAG(35:1) | cPLA2i | 1.0 | BCD110605C30 | 1.84 | pmol/sample |
| - | 1,2-DAG(35:1) | cPLA2i | 1.0 | BCD110605C29 | 0.623 | pmol/sample |
| - | 1,2-DAG(35:1) | cPLA2i | 20.0 | BCD110605C64 | 5.11 | pmol/sample |
| - | 1,2-DAG(35:1) | cPLA2i | 20.0 | BCD110605C66 | 1 | pmol/sample |
| - | 1,2-DAG(35:1) | cPLA2i | 20.0 | BCD110605C65 | 0.48 | pmol/sample |
| - | 1,2-DAG(35:1) | PLDi | 1.0 | BCD110605C16 | 2.23 | pmol/sample |
| - | 1,2-DAG(35:1) | PLDi | 1.0 | BCD110605C17 | 0.67 | pmol/sample |
| - | 1,2-DAG(35:1) | PLDi | 1.0 | BCD110605C18 | 0.799 | pmol/sample |
| - | 1,2-DAG(35:1) | PLDi | 20.0 | BCD110605C54 | 0.884 | pmol/sample |
| - | 1,2-DAG(35:1) | PLDi | 20.0 | BCD110605C52 | 3.39 | pmol/sample |
| - | 1,2-DAG(35:1) | PLDi | 20.0 | BCD110605C53 | 0.895 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+cPLA2i | 1.0 | BCD110605C32 | 0.666 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+cPLA2i | 1.0 | BCD110605C31 | 3.78 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+cPLA2i | 1.0 | BCD110605C33 | 0.87 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+cPLA2i | 20.0 | BCD110605C68 | 2.8 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+cPLA2i | 20.0 | BCD110605C69 | 1.91 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+cPLA2i | 20.0 | BCD110605C67 | 3.71 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+PLDi | 1.0 | BCD110605C19 | 2.5 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+PLDi | 1.0 | BCD110605C20 | 0.596 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+PLDi | 1.0 | BCD110605C21 | 0.459 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+PLDi | 20.0 | BCD110605C56 | 1.18 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+PLDi | 20.0 | BCD110605C57 | 1.67 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+PLDi | 20.0 | BCD110605C55 | 4.86 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C37 | 12 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C38 | 0.404 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+cPLA2i | 1.0 | BCD110605C39 | 1.25 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C74 | 1.05 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C75 | 2.38 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+cPLA2i | 20.0 | BCD110605C73 | 2.77 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+PLDi | 1.0 | BCD110605C25 | 6.48 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+PLDi | 1.0 | BCD110605C27 | 0.095 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+PLDi | 1.0 | BCD110605C26 | 0.534 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+PLDi | 20.0 | BCD110605C61 | 1.98 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+PLDi | 20.0 | BCD110605C62 | 0.932 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO+ATP+PLDi | 20.0 | BCD110605C63 | 1.17 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO + ATP | 1.0 | BCD110605C15 | 1.05 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO + ATP | 1.0 | BCD110605C14 | 0.831 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO + ATP | 1.0 | BCD110605C13 | 3.75 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO + ATP | 20.0 | BCD110605C49 | 5.24 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO + ATP | 20.0 | BCD110605C50 | 1.18 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO + ATP | 20.0 | BCD110605C51 | 2.19 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO | 1.0 | BCD110605C08 | 0.569 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO | 1.0 | BCD110605C07 | 4.61 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO | 1.0 | BCD110605C09 | 0.632 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO | 20.0 | BCD110605C45 | 1.2 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO | 20.0 | BCD110605C44 | 1.57 | pmol/sample |
| - | 1,2-DAG(35:1) | KDO | 20.0 | BCD110605C43 | 6.43 | pmol/sample |
| - | 1,2-DAG(35:1) | C | 0.0 | BCD110605C03 | 1.65 | pmol/sample |
| - | 1,2-DAG(35:1) | C | 0.0 | BCD110605C01 | 4.36 | pmol/sample |